Gene therapy of pain: emerging strategies and future directions
- 12 September 2001
- journal article
- review article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 429 (1-3) , 39-48
- https://doi.org/10.1016/s0014-2999(01)01304-8
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Met-enkephalin is preferentially transported into the peripheral processes of primary afferent fibres in both control and HSV1-driven proenkephalin A overexpressing ratsNeuroscience, 2001
- Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscleThe Journal of Gene Medicine, 1999
- Reversible Immortalization of Human Myogenic Cells by Site-Specific Excision of a Retrovirally Transferred OncogeneHuman Gene Therapy, 1999
- Nucleotide Exchange in Genomic DNA of Rat Hepatocytes Using RNA/DNA OligonucleotidesPublished by Elsevier ,1999
- Adenovirus-mediated suicide gene therapy in an in vitro model of reactive gliosisGlia, 1999
- Immunoisolated Xenogeneic Chromaffin Cell Therapy for Chronic PainAnesthesiology, 1996
- Retrovirus‐Mediated Expression of an Artificial β‐Endorphin Precursor in Primary FibroblastsJournal of Neurochemistry, 1995
- Non-viral gene transfer: Applications in developmental biology and gene therapyBiology of the Cell, 1995
- Gene Transfer into Experimental Brain Tumors Mediated by Adenovirus, Herpes Simplex Virus, and Retrovirus VectorsHuman Gene Therapy, 1994
- Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide productsNature, 1982